Get the Stockscreener App
1.63
0.61%
-0.01
After Hours:
1.66
0.03
+1.84%
Gain Therapeutics Inc stock is traded at $1.63, with a volume of 547.99K.
It is down -0.61% in the last 24 hours and down -5.78% over the past month.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
See More
Previous Close:
$1.64
Open:
$1.68
24h Volume:
547.99K
Relative Volume:
1.41
Market Cap:
$58.60M
Revenue:
$210.70K
Net Income/Loss:
$-21.37M
P/E Ratio:
-1.4818
EPS:
-1.1
Net Cash Flow:
$-21.10M
1W Performance:
-4.68%
1M Performance:
-5.78%
6M Performance:
-22.75%
1Y Performance:
+10.14%
1-Day Range:
$1.595
$1.6999
1-Week Range:
$1.595
$1.78
52-Week Range:
$1.36
$3.19
Gain Therapeutics Inc Stock (GANX) Company Profile
Name
Gain Therapeutics Inc
Sector
Industry
Phone
(301) 500-1556
Address
4800 HAMPDEN LANE, BETHESDA
Compare GANX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.63 | 58.96M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Dec-06-24 | Initiated | ROTH MKM | Buy |
| Aug-14-24 | Resumed | Oppenheimer | Outperform |
| Apr-12-21 | Initiated | BTIG Research | Buy |
| Apr-12-21 | Initiated | Oppenheimer | Outperform |
Gain Therapeutics Inc Stock (GANX) Latest News
Published on: 2025-09-16 14:43:05 - خودرو بانک
Combining machine learning predictions for Gain Therapeutics Inc.July 2025 PostEarnings & Risk Controlled Stock Pick Alerts - newser.com
What institutional flow reveals about Gain Therapeutics Inc.Sell Signal & Expert Approved Trade Ideas - newser.com
Using fundamentals and technicals on Gain Therapeutics Inc.Earnings Miss & Real-Time Chart Breakout Alerts - newser.com
Is Gain Therapeutics Inc stock trending bullishMarket Activity Report & High Accuracy Trade Signal Alerts - خودرو بانک
Pullback Watch: Can Gain Therapeutics Inc stock double in the next yearWeekly Earnings Recap & Consistent Income Trade Ideas - خودرو بانک
Aug Final Week: Is Gain Therapeutics Inc stock forming a triangle pattern2025 Key Lessons & Safe Swing Trade Setups - خودرو بانک
Gains Recap: What drives Gain Therapeutics Inc.’s stock priceShort Setup & Weekly High Potential Alerts - خودرو بانک
Street Watch: Whats the beta of Gain Therapeutics Inc stockJuly 2025 WrapUp & Smart Swing Trading Techniques - خودرو بانک
Risk adjusted return profile for Gain Therapeutics Inc. analyzedQuarterly Earnings Report & Consistent Profit Focused Trading Strategies - newser.com
Is Gain Therapeutics Inc. forming a bottoming baseBreakout Watch & Safe Capital Investment Plans - newser.com
Analyzing net buyer seller activity in Gain Therapeutics Inc.Earnings Miss & Smart Allocation Stock Reports - newser.com
How to integrate Gain Therapeutics Inc. into portfolio analysis tools2025 Top Decliners & Growth Focused Stock Reports - newser.com
Can a trend reversal in Gain Therapeutics Inc. lead to recoveryJuly 2025 Analyst Calls & Verified Momentum Stock Ideas - newser.com
Real time breakdown of Gain Therapeutics Inc. stock performancePortfolio Risk Summary & Growth Focused Entry Point Reports - newser.com
Applying Elliott Wave Theory to Gain Therapeutics Inc.Weekly Stock Analysis & Short-Term High Return Ideas - newser.com
What moving averages say about Gain Therapeutics Inc.July 2025 Retail & Smart Allocation Stock Tips - newser.com
Custom strategy builders for tracking Gain Therapeutics Inc.Price Action & Stepwise Entry/Exit Trade Alerts - newser.com
Does Gain Therapeutics Inc. show high probability of reboundMarket Trend Review & Stepwise Trade Signal Implementation - newser.com
Gain Therapeutics' (GANX) Buy Rating Reiterated at BTIG Research - MarketBeat
Forecasting Gain Therapeutics Inc. price range with options dataJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
How to use Fibonacci retracement on Gain Therapeutics Inc.July 2025 Market Mood & Reliable Entry Point Alerts - Newser
Live market analysis of Gain Therapeutics Inc.Trade Analysis Summary & Short-Term Trading Alerts - Newser
Historical volatility pattern of Gain Therapeutics Inc. visualizedMarket Growth Report & Safe Capital Growth Trade Ideas - Newser
Is Gain Therapeutics Inc. showing signs of accumulationEarnings Risk Report & Reliable Volume Spike Alerts - Newser
Custom watchlist performance reports with Gain Therapeutics Inc.Weekly Market Outlook & Weekly Stock Performance Updates - Newser
Is this a good reentry point in Gain Therapeutics Inc.July 2025 Trade Ideas & Entry Point Confirmation Signals - Newser
Technical signs of recovery in Gain Therapeutics Inc.Earnings Risk Report & Precise Trade Entry Recommendations - Newser
Using Ichimoku Cloud for Gain Therapeutics Inc. technicals2025 Dividend Review & Community Driven Trade Alerts - Newser
Order flow analysis tools used on Gain Therapeutics Inc.Weekly Trade Recap & Fast Entry Momentum Trade Alerts - Newser
Best data tools to analyze Gain Therapeutics Inc. stockMarket Growth Review & Weekly Return Optimization Alerts - Newser
Gain Therapeutics Inc Stock (GANX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):